- Previous Close
366.87 - Open
364.79 - Bid --
- Ask --
- Day's Range
349.95 - 364.79 - 52 Week Range
250.79 - 364.79 - Volume
437 - Avg. Volume
6,578 - Market Cap (intraday)
130.208B - Beta (5Y Monthly) 0.94
- PE Ratio (TTM)
0.67 - EPS (TTM)
5.26 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
www.stryker.com53,000
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0R2S.L
View MorePerformance Overview: 0R2S.L
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0R2S.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0R2S.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
13.25%
Return on Assets (ttm)
7.47%
Return on Equity (ttm)
15.26%
Revenue (ttm)
22.6B
Net Income Avi to Common (ttm)
2.99B
Diluted EPS (ttm)
5.26
Balance Sheet and Cash Flow
Total Cash (mrq)
4.49B
Total Debt/Equity (mrq)
68.43%
Levered Free Cash Flow (ttm)
2.86B